NCT00867880View on ClinicalTrials.gov

Pharmacokinetic Study Of Ibuprofen Injection (IVIb) In Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

May 31, 2009

Study Completion Date

June 30, 2009

Conditions
Healthy
Interventions
DRUG

IVIb

800mg IVIb diluted in 200mL NS will be given IV (in the vein) concurrently with an oral placebo on Day 1 and 200ml Normal Saline will be given IV (in the vein)concurrently with 800mg oral ibuprofen on Day 8

Trial Locations (1)

5032

Centre for Pharmaceutical Research, Underdale

Sponsors
All Listed Sponsors
lead

Cumberland Pharmaceuticals

INDUSTRY